A Look at Cancer Vaccines
What You Need to Know
By the National Cancer Institute
| Print Version |
Discuss Online
Vaccines are medicines that boost the immune
system's natural ability to protect the body against "foreign invaders" that may
cause disease. You probably already know that there are vaccines for a number of
diseases like the flu, measles, and even chicken pox. In fact, many deadly
infectious diseases that were capable of killing millions are now tamed because
of vaccines. Someday it may be the same for cancer
For many years, the treatment of cancer was focused primarily on surgery,
chemotherapy, and radiation. However, as researchers learn more about how the
body fights cancer on its own, so-called biological therapies, including
vaccines, are being developed that harness the potential of the body's defense
system in this fight. Some cancer vaccines, known as cancer preventive vaccines,
are designed to prevent cancer from developing in healthy people. Other cancer
vaccines, known as cancer treatment vaccines, are intended to treat cancers that
have already occurred.
Some cancer preventive vaccines are already a
reality. These types of vaccines are designed to target infectious agents that
cause cancer. One type of vaccine prevents infection with the human
papillomavirus (HPV), which causes almost all cervical cancers. The US Food and
Drug Administration has approved one HPV vaccine, Gardasil®, and in September
2009 an FDA advisory committee recommended approval of a second HPV vaccine,
Cervarix®. Both vaccines protect against infection by HPV types 16 and 18,
which, together, cause approximately 70 percent of all cases of cervical cancer
worldwide. Gardasil also protects infection by two additional HPV types that
cause most cases of genital warts. The Advisory Committee on Immunization
Practices of the Centers for Disease Control and Prevention has recommended that
girls age 11 to 12 get vaccinated (though it's appropriate to do so when they
are as young as 9) and that females aged 13 to 26 also be vaccinated.
Another cancer preventive vaccine protects against
chronic HBV infection, which can lead to liver cancer. The HBV vaccine was
approved by the FDA in 1981, making it the first cancer preventive vaccine to be
successfully developed. Today, most children in the United States are vaccinated
against HBV shortly after birth.
Cancer treatment vaccines are designed to strengthen the body's natural defenses
by stimulating the immune system to recognize and attack existing cancer cells.
These vaccines may stop a tumor from growing, stop a tumor from coming back
after it has been treated, or eliminate cancer cells not killed by previous
treatments. However, cancer treatment vaccines remain an experimental form of
therapy and the FDA has not yet approved any cancer vaccine for use as a
standard treatment.
Clinical trials that are testing promising cancer
control strategies are under way. These include studies of how best to combine
cancer treatment vaccines with other types of therapy and research on new
technologies to improve understanding of the basic biology underlying the
interaction of immune cells and cancer cells. People who take part in these
cancer clinical trials have an opportunity to contribute to knowledge of, and
progress against, cancer. They also receive up-to-date care from experts. A
database of cancer clinical trials, including vaccine trials, can also be
searched on NCI's Web site, http://www.cancer.gov, by visiting
http://www.cancer.gov/clinicaltrials/search on the Internet. To learn more about
cancer vaccines enter search keywords (such as vaccines or HPV) on NCI's Web
site.
NCI also offers comprehensive research-based
information for patients and their families, health professionals, cancer
researchers, advocates, and the public:
- Call NCI's Cancer Information Service at 1-800-4-CANCER (1-800-422-6237)
- Visit us at
http://www.cancer.gov or
http://www.cancer.gov/espanol
- Chat using LiveHelp, NCI's instant messaging service, at
http://www.cancer.gov/livehelp
- E-mail us at
cancergovstaff@mail.nih.gov
- Order publications at
http://www.cancer.gov/publications or by calling 1-800-4-CANCER
NCI leads the National Cancer Program and the NIH
effort to dramatically reduce the burden of cancer and improve the lives of
cancer patients and their families, through research into prevention and cancer
biology, the development of new interventions, and the training and mentoring of
new researchers. For more information about cancer, please visit the NCI Web
site at http://www.cancer.gov or call NCI's Cancer information Service at
1-800-4-CANCER (1800-422-6237).
to top of page
|